Health Canada authorizes Pfizer-BioNTech XFG-adapted COVID-19 vaccine

• Health Canada authorized Pfizer’s XFG-adapted Comirnaty COVID-19 vaccine for people aged 6 months and older for the 2026-2027 season.
• BioNTech partnered on the updated mRNA shot, which targets the Omicron XFG lineage.
• Doses are expected to roll out across Canada via multiple distribution channels in the coming days and weeks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202609171330CANADANWCANADAPR_C8570) on September 17, 2026, and is solely responsible for the information contained therein.